PHASE II STUDY OF INTERMITTENT ERLOTINIB (E) PLUS CARBOPLATIN (C), PACLITAXEL (P) AND BEVACIZUMAB (B) AS FRONTLINE TREATMENT OF PATIENTS (PTS) WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSNSCLC): AVAFAST STUDY

被引：0
|
作者：
Cobo Dols, Manuel A. [1 ]
Blanco, Esperanza [2 ]
Bernabe, Reyes [3 ]
Fernandez, Inmaculada [4 ]
Inoriza, Angel [5 ]
Laura Ortega, Ana [6 ]
Valdivia, Javier [7 ]
机构：
[1] Hru Carlos Haya, Malaga, Spain
[2] Hosp Infanta Cristina, Badajoz, Spain
[3] Hosp Nuestra Senora De Valme, Seville, Spain
[4] Hosp De Jerez, Cadiz, Spain
[5] Hosp Juan Ramon Jimenez, Huelva, Spain
[6] Complejo Hosp De Jaen, Jaen, Spain
[7] Hosp Univ Virgen Nieves, Granada, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
ADVANCED NSCLC; Intermittent Erlotinib; Clinical Trial in Progress;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.11-052
引用
收藏
页码：S1213 / S1213
页数：1
相关论文
共 50 条
  • [41] Phase I/II Trial of Carboplatin, nab-Paclitaxel and Bevacizumab for Advanced Non-Squamous Non-Small Cell Lung Cancer: Results of Phase I Part
    Ikeo, Satoshi
    Nogami, Naoyuki
    Kitajima, Hiromoto
    Yoshioka, Hiroshige
    Bessho, Akihiro
    Kaira, Kyoichi
    Kubo, Toshio
    Murakami, Shuji
    Watanabe, Koshiro
    Kiura, Katsuyuki
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S905 - S905
  • [42] Multicenter phase II study of cisplatin, pemetrexed, plus bevacizumab followed by maintenance pemetrexed plus bevacizumab for patients with advanced or recurrent non-squamous non-small cell lung cancer: MAP study
    Tsutani, Y.
    Miyata, Y.
    Masuda, T.
    Fujitaka, K.
    Doi, M.
    Awaya, Y.
    Kuyama, S.
    Kitaguchi, S.
    Ueda, K.
    Okada, M.
    ANNALS OF ONCOLOGY, 2017, 28 : 137 - 137
  • [43] GGCP041/09: A Galician study of second-line erlotinib in patients with advanced non-squamous non-small cell lung cancer (nsNSCLC).
    Vazquez Estevez, Sergio
    Villanueva Silva, Maria Jose
    Firvida Perez, Jose Luis
    Lazaro Quintela, Martin
    Varela Ferreiro, Silvia
    Huidobro Vence, Gerardo
    Fernandez Calvo, Ovidio
    Campos Balea, Begona
    Casal Rubio, Joaquin
    Areses Manrique, Carmen
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [44] Phase II study of carboplatin and weekly paclitaxel in advanced non-small cell lung cancer
    Nakadate, Megumi
    Yamazaki, Koichi
    Konishi, Jun
    Kinoshita, Ichiro
    Sukoh, Noriaki
    Harada, Masao
    Akie, Kenji
    Ogura, Shigeaki
    Ishida, Takashi
    Munakata, Mitsuru
    Dosaka-Akita, Hirotoshi
    Isobe, Hiroshi
    Nishimura, Masaharu
    ANTICANCER RESEARCH, 2006, 26 (5B) : 3767 - 3772
  • [45] GGCP041/09: A GALICIAN STUDY OF SECOND-LINE ERLOTINIB IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSNSCLC)
    Vazquez Estevez, S.
    Villanueva Silva, M. J.
    Firvida Perez, J. L.
    Lazaro Quintela, M.
    Varela Ferreiro, S.
    Huidobro Vence, G.
    Fernandez Calvo, O.
    Campos Balea, B.
    Grande Ventura, C.
    Areses, K.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S67 - S67
  • [46] Phase I Study of Carboplatin Combined with Pemetrexed for Elderly Patients with Advanced Non-squamous Non-small Cell Lung Cancer
    Takeoka, Hiroaki
    Yamada, Kazuhiko
    Azuma, Koichi
    Zaizen, Yoshiaki
    Yamashita, Fumie
    Yoshida, Tsukasa
    Naito, Yoshiko
    Okayama, Yusuke
    Miyamoto, Maki
    Hoshino, Tomoaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (05) : 472 - 478
  • [47] Bevacizumab Plus Carboplatin Plus Nab-paclitaxel for Non-squamous Non-small Cell Lung Cancer in a Real-world Setting
    Tamiya, Akihiro
    Tamiya, Motohiro
    Inagaki, Yuji
    Taniguchi, Yoshihiko
    Nakao, Keiko
    Matsuda, Yoshinobu
    Kawamura, Takahisa
    Kunimasa, Kei
    Inoue, Takako
    Nishino, Kazumi
    Okishio, Kyoichi
    ANTICANCER RESEARCH, 2023, 43 (03) : 1325 - 1330
  • [48] Bevacizumab and weekly paclitaxel for non-squamous non small cell lung cancer patients: A retrospective study
    Habib, Stefanie
    Delourme, Julie
    Dhalluin, Xavier
    Petyt, Gregory
    Tacelli, Nunzia
    Scherpereel, Arnaud
    Lafitte, Jean-Jacques
    Cortot, Alexis B.
    LUNG CANCER, 2013, 80 (02) : 197 - 202
  • [49] A randomized phase II study of paclitaxel (P) and carboplatin (C) ± bevacizumab (B) ± dulanermin (D) in non-small lung cancer (NSCLC)
    Blackhall, F. H.
    Mark, Z.
    Zatloukal, P.
    Szima, B.
    Albert, I.
    Juhasz, E.
    Yang, X.
    Smethurst, D.
    Hei, Y.
    Soria, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [50] Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer
    Niho, Seiji
    Kunitoh, Hideo
    Nokihara, Hiroshi
    Horai, Takeshi
    Ichinose, Yukito
    Hida, Toyoaki
    Yamamoto, Nobuyuki
    Kawahara, Masaaki
    Shinkai, Tetsu
    Nakagawa, Kazuhiko
    Matsui, Kaoru
    Negoro, Shunichi
    Yokoyama, Akira
    Kudoh, Shinzoh
    Kiura, Katsuyuki
    Mori, Kiyoshi
    Okamoto, Hiroaki
    Sakai, Hiroshi
    Takeda, Koji
    Yokota, Soichiro
    Saijo, Nagahiro
    Fukuoka, Masahiro
    LUNG CANCER, 2012, 76 (03) : 362 - 367
12345